• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为了在拉丁美洲和加勒比地区建立多发性硬化症的患病率。

Towards establishing MS prevalence in Latin America and the Caribbean.

机构信息

Foundation for Neuroepidemiology Research, Junín, Argentina.

出版信息

Mult Scler. 2013 Feb;19(2):145-52. doi: 10.1177/1352458512441985. Epub 2012 Apr 4.

DOI:10.1177/1352458512441985
PMID:22492129
Abstract

A very high prevalence of multiple sclerosis (MS) has been reported in some Western European and North American countries. The few surveys of MS epidemiology in South America reveal lower prevalence rates, implying that susceptibility varies between distinct ethnic groups, thus forming an important determinant of the geographic distribution of the disease. The objective of this study is to review MS prevalence estimates in different Latin American and Caribbean countries. We reviewed surveys of regional MS prevalence from 1991 to 2011. Sources included an online database, authors' reports and proceedings or specific lectures from regional conferences. We obtained a total of 30 prevalence surveys from 15 countries, showing low/medium MS prevalence rates. Both the number and the quality of prevalence surveys have greatly improved in this region over recent decades. This is the first collaborative study to map the regional frequency of MS. Establishment of standardized methods and joint epidemiological studies will advance future MS research in Latin America and the Caribbean.

摘要

一些西欧和北美国家报告多发性硬化症(MS)的发病率非常高。在南美洲进行的少数几项 MS 流行病学调查显示,发病率较低,这意味着不同种族群体之间的易感性存在差异,因此形成了疾病地理分布的重要决定因素。本研究的目的是综述拉丁美洲和加勒比地区不同国家的 MS 患病率估计值。我们回顾了 1991 年至 2011 年的区域性 MS 患病率调查。来源包括在线数据库、作者报告以及区域会议的论文集或专题演讲。我们从 15 个国家共获得了 30 项患病率调查,结果显示这些国家的 MS 发病率处于低/中水平。近几十年来,该地区的患病率调查数量和质量都有了很大的提高。这是首次对拉丁美洲和加勒比地区 MS 区域频率进行的协作研究。建立标准化方法和联合流行病学研究将推动拉丁美洲和加勒比地区未来的 MS 研究。

相似文献

1
Towards establishing MS prevalence in Latin America and the Caribbean.为了在拉丁美洲和加勒比地区建立多发性硬化症的患病率。
Mult Scler. 2013 Feb;19(2):145-52. doi: 10.1177/1352458512441985. Epub 2012 Apr 4.
2
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.拉丁美洲和加勒比地区多发性硬化症的流行病学:系统评价。
Mult Scler. 2013 Jun;19(7):844-54. doi: 10.1177/1352458512462918. Epub 2012 Oct 8.
3
Latitudinal prevalence gradient of multiple sclerosis in Latin America.拉丁美洲多发性硬化症的纬度流行梯度。
Mult Scler. 2011 Sep;17(9):1055-9. doi: 10.1177/1352458511405562. Epub 2011 May 6.
4
Estimating the number of men who have sex with men in low and middle income countries.估算低收入和中等收入国家中男男性行为者的数量。
Sex Transm Infect. 2006 Jun;82 Suppl 3(Suppl 3):iii3-9. doi: 10.1136/sti.2005.019489.
5
HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?拉丁美洲和加勒比地区的 HIV-1 传播耐药性:我们了解多少?
AIDS Rev. 2012 Oct-Dec;14(4):256-67.
6
Population and development in Latin America and the Caribbean.拉丁美洲和加勒比地区的人口与发展
UFSI Rep. 1983(7):1-11.
7
[There are many variations in beginning and duration of the procreative period].生殖期的开始时间和持续时间存在许多差异。
Perspect Int Planif Fam. 1987(Spec No):37-8.
8
Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America.加勒比地区以及北美洲、中美洲和南美洲中PI*S和PI*Zα-1抗胰蛋白酶缺乏症等位基因流行率的估计。
Monaldi Arch Chest Dis. 2009 Sep;71(3):96-105. doi: 10.4081/monaldi.2009.354.
9
Zinc Deficiency in Latin America and the Caribbean.拉丁美洲和加勒比地区的锌缺乏情况。
Food Nutr Bull. 2015 Jun;36(2 Suppl):S129-38. doi: 10.1177/0379572115585781.
10
Trends in cervical cancer mortality in the Americas.美洲宫颈癌死亡率趋势。
Bull Pan Am Health Organ. 1996 Dec;30(4):290-301.

引用本文的文献

1
Multiple sclerosis in Central America and Caribbean countries: frequency and clinical characterization of an emergent disease.中美洲和加勒比国家的多发性硬化症:一种新兴疾病的发病率及临床特征
Front Epidemiol. 2024 Jun 17;4:1368675. doi: 10.3389/fepid.2024.1368675. eCollection 2024.
2
Prevalence of multiple sclerosis in Cuenca, Ecuador.厄瓜多尔昆卡市多发性硬化症的患病率。
Mult Scler J Exp Transl Clin. 2019 Oct 30;5(4):2055217319884952. doi: 10.1177/2055217319884952. eCollection 2019 Oct-Dec.
3
A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015.
2006年至2015年巴伐利亚州多发性硬化症患病率、发病率及区域分布的系统评估
Front Neurol. 2018 Oct 30;9:871. doi: 10.3389/fneur.2018.00871. eCollection 2018.
4
Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.墨西哥威克萨卡族人群中多发性硬化症风险单倍型 HLA-DR2 的标签多态性缺失。
Immunogenetics. 2018 Aug;70(8):547-551. doi: 10.1007/s00251-018-1052-8. Epub 2018 Feb 3.
5
Application of the McDonald criteria in Latin America.麦克唐纳标准在拉丁美洲的应用。
Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317721943. doi: 10.1177/2055217317721943. eCollection 2017 Jul-Sep.
6
Environmental factors influencing multiple sclerosis in Latin America.影响拉丁美洲多发性硬化症的环境因素。
Mult Scler J Exp Transl Clin. 2017 Jun 13;3(2):2055217317715049. doi: 10.1177/2055217317715049. eCollection 2017 Apr-Jun.
7
Prevalence of multiple sclerosis in Latin America and its relationship with European migration.拉丁美洲多发性硬化症的患病率及其与欧洲移民的关系。
Mult Scler J Exp Transl Clin. 2016 Sep 2;2:2055217316666407. doi: 10.1177/2055217316666407. eCollection 2016 Jan-Dec.
8
Orofacial evaluation in patients with multiple sclerosis using Nordic Orofacial Test-Screening.应用北欧口腔测试筛选对多发性硬化症患者的口腔面部评估。
Clin Oral Investig. 2017 Jun;21(5):1681-1685. doi: 10.1007/s00784-016-1952-7. Epub 2016 Sep 6.
9
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.巴西多发性硬化症的成本分析:一项横断面多中心研究。
BMC Health Serv Res. 2016 Mar 24;16:102. doi: 10.1186/s12913-016-1352-3.
10
Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study.通过巴西和英国价值集获得的效用评分差异:一项横断面研究。
Health Qual Life Outcomes. 2015 Aug 6;13:119. doi: 10.1186/s12955-015-0318-1.